Bo Hjorth Bentzen

Medicine & Life Sciences

1. (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine 23%
2. 1,3-bis(2-hydroxy-5-trifluoromethylphenyl)urea 38%
3. 1-(3,5-bis(trifluoromethyl)phenyl)-3-(4-bromo-2-(1H-tetrazol-5-yl)phenyl)thiourea 60%
4. 2,6-bis(benzimidazol-2-yl)pyridine 23%
5. 2-(3,5-difluorophenyl)-N-(6-((4-fluorophenyl)methylamino)-2-morpholino-3-pyridyl)acetamide 23%
6. 4-boronic acid benzophenone 17%
7. Action Potentials 64%
8. Anti-Arrhythmia Agents 16%
9. AP14145 52%
10. Atrial Fibrillation 100%
11. BMS204352 17%
12. Calcium-Activated Potassium Channels 29%
13. Cardiac Arrhythmias 19%
14. Cardiac Myocytes 16%
15. dofetilide 20%
16. ezogabine 19%
17. Genetic Variation 17%
18. Guinea Pigs 25%
19. Heart 69%
20. Hypokalemia 15%
21. Ion Channels 21%
22. Ischemia 18%
23. KCNQ Potassium Channels 17%
24. Large-Conductance Calcium-Activated Potassium Channels 53%
25. Magnetocardiography 15%
26. Membrane Potentials 16%
27. Mesenteric Arteries 19%
28. NS13558 22%
29. Oocytes 15%
30. Pharmacology 25%
31. Potassium 17%
32. Potassium Channels 31%
33. Reperfusion Injury 30%
34. Romano-Ward Syndrome 15%
35. Small-Conductance Calcium-Activated Potassium Channels 85%
36. Sodium Channels 32%
37. Tesofensine 19%
38. Unsaturated Fatty Acids 19%
39. vernakalant 16%
40. Voltage-Gated Potassium Channels 15%
41. Xenopus laevis 18%